Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term adverse effects. Found 219 abstracts

no pagination
Su S, Scott WJ, Allen MS, Darling GE, Decker PA, McKenna RJ, Meyers BF. Patterns of survival and recurrence after surgical treatment of early stage non-small cell lung carcinoma in the ACOSOG Z0030 (ALLIANCE) trial. The Journal of thoracic and cardiovascular surgery. 2014 Feb;147(2):747-52: Discussion 752-3.
Tomaszewski JJ, Smaldone MC, Cung B, Li T, Mehrazin R, Kutikov A, Canter DJ, Viterbo R, Chen DY, Greenberg RE, Uzzo RG. Internal validation of the renal pelvic score: a novel marker of renal pelvic anatomy that predicts urine leak after partial nephrectomy. Urology. 2014 Aug;84(2):351-7.   PMCID: Pmc4115009
Tu Y, Hershman DL, Bhalla K, Fiskus W, Pellegrino CM, Andreopoulou E, Makower D, Kalinsky K, Fehn K, Fineberg S, Negassa A, Montgomery LL, Wiechmann LS, Alpaugh RK, Huang M, Sparano JA. A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer. Breast Cancer Res Treat. 2014 Jul;146(1):145-52.
Twelves C, Chmielowska E, Havel L, Popat S, Swieboda-Sadlej A, Sawrycki P, Bycott P, Ingrosso A, Kim S, Williams JA, Chen C, Olszanski AJ, de Besi P, Schiller JH. Randomised phase II study of axitinib or bevacizumab combined with paclitaxel/carboplatin as first-line therapy for patients with advanced non-small-cell lung cancer. Ann Oncol. 2014 Jan;25(1):132-8.   PMCID: No NIH funds
Weinberg DS, Smalley W, Heidelbaugh JJ, Sultan S. American Gastroenterological Association Institute Guideline on the pharmacological management of irritable bowel syndrome. Gastroenterology. 2014 Nov;147(5):1146-8.
Yamoah K, Eldredge-Hindy HB, Zaorsky NG, Palmer JD, Doyle LA, Sendecki JA, Hesney AA, Harper L, Repka M, Showalter TN, Hurwitz MD, Dicker AP, Den RB. Large prostate gland size is not a contraindication to low-dose-rate brachytherapy for prostate adenocarcinoma. Brachytherapy. 2014 Sep;13(5):456-64.
Zaorsky NG, Doyle LA, Hurwitz MD, Dicker AP, Den RB. Do theoretical potential and advanced technology justify the use of high-dose rate brachytherapy as monotherapy for prostate cancer?. Expert Rev Anticancer Ther. 2014 Jan;14(1):39-50.
Cohen RB, Aamdal S, Nyakas M, Cavallin M, Green D, Learoyd M, Smith I, Kurzrock R. A phase I dose-finding, safety and tolerability study of AZD8330 in patients with advanced malignancies. Eur J Cancer. 2013 May;49(7):1521-9.   PMCID: *
Schilder RJ, Sill MW, Lankes HA, Gold MA, Mannel RS, Modesitt SC, Hanjani P, Bonebrake AJ, Sood AK, Godwin AK, Hu W, Alpaugh RK. A phase II evaluation of motesanib (AMG 706) in the treatment of persistent or recurrent ovarian, fallopian tube and primary peritoneal carcinomas: a Gynecologic Oncology Group study. Gynecol Oncol. 2013 Apr;129(1):86-91.   PMCID: PMC 3712785
Siddiqui UD, Banerjee S, Barth B, Chauhan SS, Gottlieb KT, Konda V, Maple JT, Murad FM, Pfau PR, Pleskow DK, Tokar JL, Wang A, Rodriguez SA. Tools for endoscopic stricture dilation. Gastrointestinal endoscopy. 2013 Sep;78(3):391-404.   PMCID: No NIH funds
Sterious S, Simhan J, Uzzo RG, Gershman B, Li T, Devarajan K, Canter D, Walton J, Fogg R, Ginzburg S, Corcoran A, Smaldone MC, Kutikov A. Familiarity and self-reported compliance with American Urological Association best practice recommendations for use of thromboembolic prophylaxis among American Urological Association members. J Urol. 2013 Sep;190(3):992-8.
Wang A, Banerjee S, Barth BA, Bhat YM, Chauhan S, Gottlieb KT, Konda V, Maple JT, Murad F, Pfau PR, Pleskow DK, Siddiqui UD, Tokar JL, Rodriguez SA. Wireless capsule endoscopy. Gastrointestinal endoscopy. 2013 Dec;78(6):805-15.
Asge Technology Committee, Wang A, Pleskow DK, Banerjee S, Barth BA, Bhat YM, Desilets DJ, Gottlieb KT, Maple JT, Pfau PR, Siddiqui UD, Tokar JL, Song LM, Rodriguez SA. Esophageal function testing. Gastrointestinal endoscopy. 2012 Aug;76(2):231-43.   PMCID: not NIH funded
Dotan E, Meropol NJ, Burtness B, Denlinger CS, Lee J, Mintzer D, Zhu F, Ruth K, Tuttle H, Sylvester J, Cohen SJ. A phase II study of capecitabine, oxaliplatin, and cetuximab with or without bevacizumab as frontline therapy for metastatic colorectal cancer. A Fox Chase extramural research study. J Gastrointest Cancer. 2012 Dec;43(4):562-9.   PMCID: 3400721
Turaka A, Parsons RB, Buyyounouski MK. Radiation therapy for pituitary metastasis: report of four cases. Tumori. 2012 Jan;98(1):e1-6.   PMCID: Not NIH funded
Asge Technology Committee, Tokar JL, Banerjee S, Barth BA, Desilets DJ, Kaul V, Kethi SR, Pedrosa MC, Pfau PR, Pleskow DK, Varadarajulu S, Wang A, Song LM, Rodriguez SA. Drug-eluting/biodegradable stents. Gastrointestinal endoscopy. 2011 Nov;74(5):954-8.   PMCID: not NIH funded
Asge Technology Committee, Varadarajulu S, Banerjee S, Barth B, Desilets D, Kaul V, Kethu S, Pedrosa M, Pfau P, Tokar J, Wang A, Song LM, Rodriguez S. Enteral stents. Gastrointestinal endoscopy. 2011 Sep;74(3):455-64.   PMCID: not NIH funded
Dees EC, Infante JR, Cohen RB, O'Neil BH, Jones S, von Mehren M, Danaee H, Lee Y, Ecsedy J, Manfredi M, Galvin K, Stringer B, Liu H, Eton O, Fingert H, Burris H. Phase 1 study of MLN8054, a selective inhibitor of Aurora A kinase in patients with advanced solid tumors. Cancer Chemother Pharmacol. 2011 Apr;67(4):945-54.   PMCID: PMC3026871
Held-Warmkessel J. Taming three high-risk chemotherapy complications. Nursing. 2011 Nov;41(11):30-7.   PMCID: not NIH funded
Ma CM, Luxton G, Orton CG. Point/counterpoint: pulsed reduced dose rate radiation therapy is likely to become the treatment modality of choice for recurrent cancers. Med Phys. 2011 Sep;38(9):4909-11.   PMCID: not NIH funded
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term adverse effects

adverse effects Male Female Middle Aged methods Aged Treatment Outcome pathology therapeutic use drug therapy etiology Adult administration & dosage chemically induced economics Kaplan-Meier Estimate United States radiotherapy diagnosis Drug Administration Schedule Neoplasm Staging Lung Neoplasms therapy antagonists & inhibitors Proportional Hazards Models Local Neoplasm Recurrence Adenocarcinoma surgery 80 and over Aged Disease-Free Survival Protein Kinase Inhibitors Radiotherapy Dosage Neoplasms complications Non-Small-Cell Lung Carcinoma Antineoplastic Combined Chemotherapy Protocols instrumentation Paclitaxel metabolism secondary Retrospective Studies Dose Fractionation Survival Rate pharmacokinetics mortality Antineoplastic Agents Pathologic Constriction Intestinal Diseases Tumor Biomarkers Neutropenia Gastrointestinal Diseases Esophageal Stenosis Prostatic Neoplasms Young Adult Brachytherapy blood Esophageal Diseases Prospective Studies analogs & derivatives Pancreatic Diseases Drug Dose-Response Relationship anatomy & histology Risk Factors standards Monoclonal Antibodies-Humanized Prostate cancer Absorbable Implants X-Ray Computed Tomography Protein-Tyrosine Kinases Dbe Gastrointestinal Hemorrhage Stents Internet Propensity Score Digestive System Endoscopy Angiogenesis Inhibitors Ki-67 Antigen Maximum Tolerated Dose Acne Vulgaris Fever Fatigue Headache Pneumonectomy Vascular Endothelial Growth Factor A Esophagus Fatal Outcome Questionnaires Kidney Pelvis Urologic Surgical Procedures Multivariate Analysis Area Under Curve Gastrointestinal Agents Breast Neoplasms Hydroxamic Acids Gastroenterology Adjuvant Chemoradiotherapy Fallopian Tube Neoplasms Esophageal pH Monitoring Aurora Kinases Wce nonsteroidal anti-inflammatory drug through-the-scope Half-Life Magnetic Resonance Imaging Colon Cross-Sectional Studies MAP Kinase Kinase 2 Fda Metabolic Clearance Rate Cyclin-Dependent Kinase Inhibitor p21 chemotherapy Palliative Care Disorders of Excessive Somnolence Intensity-Modulated Radiotherapy Confusion genetics Low-dose rate Imidazoles Capsule Endoscopes Celiac Disease adverse Dermatitis Seps Indazoles physiopathology Oral Administration Bevacizumab Radiotherapy Combination Drug Therapy Practice Guidelines as Topic Catheters effects Dilatation Kidney Neoplasms Deglutition Disorders Capsule Endoscopy non-squamous Prognosis Adolescent Fluorouracil Psc Medical Records Stereotaxic Techniques Venous Thromboembolism Neoplasm DNA Sems radiation effects non-small-cell lung cancer wireless capsule endoscopy bevacizumab
Last updated on Friday, January 03, 2020